Indeed, my difficulty oil the present occasion does not depend so much on the lack of materials as on the complicated relations of the subject, which makes me almost despair of being able, in the short time that can be devoted to a lecture, to give in anything like an intelligible form even an adequate selection of the facts at my disposal. ' The task of producing, within reasonable compass, an account of the same subject, at the present time, is no easier. There has been a very considerable increase in the number of publications on blood coagulation during the first half of this century. Examination of figures taken from the Quarterly Cumulative Index reveals that the number of articles published on this subject was twenty-five times greater in 1950 than in 1900.
Blood coagulation lias a definite role in the haemostatic mechanism. This role is only partially understood, but it is common knowledge that defective coagulation may lead to fatal haemorrhage, or to chronic invalidism. Despite this, blood coagulation research has been regarded until recent times rather as an academic hobby; most general practitioners and, indeed, many hospital consultants have tended to regard with detached amusement and tolerance the apparently increasing confusion of the subject created by their own academic colleagues. More The phases of development of our knowledge of blood coagulation can usefully be divided into three periods related to the so-called Classical Theory of blood coagulation (Morawitz,1904) , which stood unchallenged for almost fortv vears.
Pre-Classical Era {Prior to 1904). In 1835, Andrew Buchanan, working in Glasgow, reported that he could prepare from the washings of a freshly formed blood clot a substance which would coagulate hydrocoele fluid (Buchanan, 1835 (Buchanan, , 1845 (Table la) . It had been observed by Malpighi in 1666 that strands of fibres remained after washing a blood clot and the term fibrin has been adopted to describe this material (Malpighi, 1666 (Schmidt, 1861 (Schmidt, , 1862 (Schmidt, , 1893 . He was able to prepare this substance by alcohol precipitation of fresh serum. Using Schmidt's terminology, Buchanan' s observations can be represented as shown in Table lb. Fibrinogen. Hammarsteu (1877) found that there could be produced by salt precipitation of plasma a precipitate which, on being dissolved and then acted upon by the thrombin, resulted in fibrin formation. This solution must, therefore, contain a percursor of fibrin, which was called fibrinogen (Table lc) .
Prothrombin. Schmidt prepared his thrombin by alcohol precipitation of fresh serum, but using similar techniques was unable to obtain it from plasma. He postulated, therefore, that the thrombin arose during clotting from an inactive precursor in the plasma, which was called prothrombin by Pekelharing (Quick, 1951) (Table Id) . Tissue extracts. About this time it was shown that tissue extracts when added to whole blood, greatly accelerated the coagulation (Schmidt, 1893) . When blood, collected without tissue contamination, was delivered into a tube containing tissue extract and some also into a clean tube, the coagulation occurred in the first tube in a few seconds, whereas in the clean tube *t Was much less rapid. Such tissue extracts were, however, unable to cl?t the preparations of fibrinogen. Schmidt suggested, therefore, that these tissue extracts must facilitate the production of thrombin from prothrombin (Table Id) . (Table Id) .
Classical Era (1904 Era ( -1942 . Classical Theory. Morawitz, in 1904 , assembled the available data on blood coagulation and formulated his theory, which has become known as the Classical Theory (Table le) (Quick, 1935 (Quick, , 1938 Post-Classical Era (1942 (Owren, 1947 Seegers, 1950; Douglas & Biggs, 1953) . Factor V is believed to be synonymous with clotting components described by other workers ; these are summarized in Table 3 .
The term factor VI was applied to explain certain experimental phenomena which can probably now be accounted for without the introduction of a new factor, and consequently the term is now seldom used. Proaccelerin and accelerin (renamed by Owren, 1951b) . Labile factor (Quick, 1943) . Accelerator of prothrombin conversion (Fantl & Nance, 194(i) . Plasma accelerator globulin (Ware & Seegers, 1948) .
Factor VII may be called :?
Prothrombin conversion accelerator (Owen & Bollman, 1948) . Serum prothrombin conversion accelerator (S.l'.C.A.) (Vries et al., 1949) .
Proconvertin and convertin (Owren, 1951a &b).
Co-thromboplastin (Mann & Hum, 1951 (Roller et al., 1951) . It is studied usually in serum, and is prepared from serum by adsorption on alumina and elution, because there it occurs free from prothrombin which has been consumed during clotting.
Inhere is no reason to believe that it does not occur in plasma, but its study this medium is complicated by the presence of prothrombin. Roller and his co-workers, by special techniques involving Seitz filtration of plasma, were able to produce a preparation of prothrombin apparently free from factors V and VII (Roller et al., 1951 (Biggs al., 1953c . The further importance of this intrinsic mechanism was suggested by the observations of Brown (1951) , that brain extract prepared from a haemophiliac who died of haemorrhage, was as powerful as normal brain extract in the clotting of haemophilic plasma. This was an observation of fundamental importance for it would indicate that, in man, an efficient extrinsic thromboplastin mechanism is not sufficient to produce satisfactory physiological haemostasis.
The relative importance of the intrinsic mechanism as compared with the extrinsic cannot at present be assessed. Since damage to tissue is an invariable accompaniment of accidentally occurring haemorrhage it is likely that it plays some role in the control of bleeding. The serious consequence of disturbance of the blood's own thromboplastin can readily be appreciated in haemophilia. There is in vitro evidence that the blood thromboplastin is at least as powerful as the most potent preparations of tissue thromboplastin (Bordet & Delange, 1912 ; Brinkhous, 1939 ; Soulier, 1948 ; Quick et al., 1949 (Douglas, 1954a (Weiner, 1953) . Haemophilia B (Soulier & Larrieu, 1953 ; Cramer et ul., 1953) .
Haemophilioid?State C (Graham & Brinkhous, 1953) . Platelet Co-Factor-2 Deficiency (Seegers,1954) . Beta-prothromboplastin Deficiency (KantI it Sawcrs, 1954).
Factor IX Deficiency (Roller, 1954) .
Haemophilia (lack of antihaeniophilic globulin) may be called :
Haemophilia A (Soulier & Larrieu, 1953) . Haemophilia I (Weiner, 1953 (Douglas, 1954b (Douglas, 1954b) . This latter may be the more important because heparin interferes at this stage in very high dilution (Biggs et al., 1953c) . The coumarin group of drugs interferes with the formation of extrinsic thromboplastin in virtue of a quantitative depression of factor VII (Douglas, 1952) ; there is to a lesser extent depression of prothrombin itself, and there is evidence of interference with intrinsic thromboplastin formation which may represent the important action of the drug. The serum from patients under treatment with the coumarin group of drugs is defective in its ability to form blood thromboplastin ; the explanation of this defective reaction is as yet unknown (Douglas, 1955a & b A suitable technique is that described by Dacie (1950 Dacie ( , 1954 time. Factor V is diagnosed when there is significant shortening of the clotting time on the addition of 10% alumina-treated plasma but not of serum. The alumina-treated plasma contains factor V but not factor VII. Factor VII deficiency is diagnosed when there is shortening on the addition of serum but not of adsorbed plasma. The serum contains factor VII but no factor V. The method of differentiation between deficiencies of factors V and VII, both of which cause prolongation of the one-stage clotting time, is summarized in Table 9 . It is dependent upon the effect on the one-stage clotting time of the addition of factor V freed from factor VII or of factor VII freed from factor V.
If the deficiency is of factor V, then the one-stage clotting time is shortened by the addition of adsorbed plasma which contains factor V but not factor VII or prothrombin. If the deficiency is of factor VII then the one-stage clotting time is shortened by the addition of normal serum which contains factor VII but not factor V or prothrombin. These techniques are described in greater detail by . (Biggs & Douglas, 1953) , and the globulin fraction method (Douglas & Biggs, 1953 
Fibrinogen
Idiopathic.
Liver disease.
Hereditary. Possibly intravascular clotting in pregnancy or after pulmonary operations.
ii.
Interference with reactions within the coagulation mechanism.
Thrombin-fibrinogen reaction.
Heparin. Deficiency of fibrinogen.
formation of intrinsic thromboplastin.
Heparin. Circulating anticoagulants.
iii. Destruction of fibrin.
-Active fibrinolysis. (Ackroyd 1955) . In thrombocytopenia there is in consequence of the absence of platelets a disturbance of blood thromboplastin formation. In some cases of idiopathic thrombocytopenia there is evidence of coexisting capillary abnormality (Macfarlane, 1941 (Hougie, 1955 
